BS
ABBV icon

Boenning & Scattergood’s AbbVie ABBV Stock Holding History

Boenning & Scattergood’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$13.1M Buy
80,679
+11,394
+16% +$1.75M 2.1% 4
2022
Q3 		$9.3M Sell
69,285
-9,715
-12% -$1.39M 1.9% 6
2022
Q2 		$12.1M Sell
79,000
-1,679
-2% -$257K 2.29% 4
2022
Q1 		$13.1M Sell
80,679
-774
-1% -$112K 2.1% 4
2021
Q4 		$11M Sell
81,453
-1,511
-2% -$178K 1.76% 6
2021
Q3 		$8.95M Sell
82,964
-3,991
-5% -$456K 1.57% 8
2021
Q2 		$9.79M Buy
86,955
+3,100
+4% +$349K 1.71% 8
2021
Q1 		$9.07M Buy
83,855
+5,253
+7% +$562K 1.73% 7
2020
Q4 		$8.42M Sell
78,602
-286
-0.4% -$27.5K 1.78% 7
2020
Q3 		$6.91M Buy
78,888
+152
+0.2% +$14.3K 1.66% 8
2020
Q2 		$7.73M Buy
78,736
+1,201
+2% +$106K 2.06% 5
2020
Q1 		$5.91M Sell
77,535
-1,059
-1% -$90.2K 2.04% 6
2019
Q4 		$6.96M Buy
78,594
+4,919
+7% +$408K 1.79% 9
2019
Q3 		$5.58M Buy
73,675
+9,858
+15% +$676K 1.61% 10
2019
Q2 		$4.64M Buy
63,817
+2,349
+4% +$185K 1.36% 12
2019
Q1 		$4.95M Buy
61,468
+15,857
+35% +$1.3M 1.48% 11
2018
Q4 		$4.21M Sell
45,611
-220
-0.5% -$19.3K 1.47% 11
2018
Q3 		$4.33M Sell
45,831
-2,181
-5% -$207K 1.38% 11
2018
Q2 		$4.45M Buy
+48,012
New +$4.69M 1.46% 11

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boenning & Scattergood's ABBV Position: Q4 2022 in Review

Boenning & Scattergood increased its AbbVie (ABBV) stake by 16% in Q4 2022, buying an estimated $1.75M and bringing the position to 80,679 shares worth $13.1M. The position accounts for 2.1% of the portfolio, ranked #4.

Boenning & Scattergood first reported a position in ABBV in Q2 2018 and has held it in 19 quarters since. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Boenning & Scattergood held 80,679 shares of AbbVie worth $13.1M as of Q4 2022.
  • Boenning & Scattergood bought 11,394 AbbVie shares in Q4 2022, an estimated $1.75M.
  • AbbVie made up 2.1% of Boenning & Scattergood's portfolio in Q4 2022, its #4 holding.
  • Boenning & Scattergood first reported a position in AbbVie in Q2 2018 and has held it in 19 quarters since.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.